Susanna Naggie, MD

Publications

Naggie, S. "Hepatitis C Virus, Inflammation, and Cellular Aging: Turning Back Time." Topics in antiviral medicine 25, no. 1 (February 2017): 3-6. (Review)

PMID
28402927
Scholars@Duke

Naggie, S, and Muir, AJ. "Oral Combination Therapies for Hepatitis C Virus Infection: Successes, Challenges, and Unmet Needs." Annual review of medicine 68 (January 2017): 345-358.

PMID
27686017
Full Text

Naggie, S, Holland, DP, Sulkowski, MS, and Thomas, DL. "Hepatitis C Virus Postexposure Prophylaxis in the Healthcare Worker: Why Direct-Acting Antivirals Don't Change a Thing." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 64, no. 1 (January 2017): 92-99.

PMID
27682067
Full Text

Alam, I, Brown, K, Donovan, C, Forlenza, J, Lauwers, K, Mah'moud, MA, Manch, R, Mohanty, SR, Prabhakar, A, Reindollar, R, DeMasi, R, Slim, J, Tandon, N, Villadiego, S, and Naggie, S. "Real-World Effectiveness of Simeprevir-containing Regimens Among Patients With Chronic Hepatitis C Virus: The SONET Study." Open Forum Infectious Diseases 4, no. 1 (January 2017): ofw258-.

PMID
28480251
Full Text

Younossi, ZM, Stepanova, M, Sulkowski, M, Naggie, S, Henry, L, and Hunt, S. "Sofosbuvir and ledipasvir improve patient-reported outcomes in patients co-infected with hepatitis C and human immunodeficiency virus." JOURNAL OF VIRAL HEPATITIS 23, no. 11 (November 2016): 857-865.

Full Text

Younossi, ZM, Stepanova, M, Sulkowski, M, Naggie, S, Henry, L, and Hunt, S. "Sofosbuvir and ledipasvir improve patient-reported outcomes in patients co-infected with hepatitis C and human immunodeficiency virus." November 2016.

PMID
27291391
Full Text

Chan, AW, Bryan, WE, Hashem, MA, Townsend, ML, Wang, LA, Choi, SS, and Naggie, S. "Hepatitis C (HCV) Virologic Outcomes in Veterans taking Ledipasvir/Sofosbuvir with Concomitant Acid Suppressing Medication." October 2016.

Scholars@Duke

Asselah, T, Shiha, G, Feld, JJ, Abergel, A, Kohli, A, Kottilil, S, Ruane, PJ, Naggie, S, Letterio, C, Hahambis, TA, Llewellyn, J, Natha, M, Kersey, K, McNally, J, Brainard, DM, and Esmat, GE. "Integrated Analysis of SOF plus RBV, LDV/SOF or SOF/VEL for the Treatment of Genotype 4 Chronic HCV Infection." October 2016.

Scholars@Duke

Naggie, S, Rosenthal, E, Kattakuzhy, S, McGinnis, J, Naik, S, Natha, M, Llewellyn, J, Haubrich, R, Osinusi, AO, Stamm, LM, Cooper, C, Dieterich, DT, and Sulkowski, MS. "Real World Effectiveness of Ledipasvir/Sofosbuvir (LDV/SOF) in Patients Coinfected With HCV and HIV-1: A Comparative Analysis of Clinical Trials with Four Real World Cohorts." October 2016.

Scholars@Duke

Sulkowski, MS, Cooper, C, Molina, J-M, Naggie, S, Huang, KC, Osinusi, AO, Stamm, LM, Massetto, B, McNally, J, Brainard, DM, McHutchison, JG, Wyles, DL, Rockstroh, JK, and Dieterich, DT. "High Rates of Medical and Psychiatric Comorbidities in HIV/HCV Coinfected Patients Treated With Sofosbuvir-Containing Regimens in Registrational Clinical Trials." October 2016.

Scholars@Duke

Pages